Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL050590-03
Application #
2226839
Study Section
Pathology A Study Section (PTHA)
Project Start
1994-07-18
Project End
1998-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Krijgsveld, J; Zaat, S A; Meeldijk, J et al. (2000) Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 275:20374-81
Ueda, Y; Royer, L; Gong, E et al. (1999) Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 274:7165-71
Boffelli, D; Zajchowski, D A; Yang, Z et al. (1999) Estrogen modulation of apolipoprotein(a) expression. Identification of a regulatory element. J Biol Chem 274:15569-74
Lou, X J; Boonmark, N W; Horrigan, F T et al. (1998) Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice. Proc Natl Acad Sci U S A 95:12591-5
Lawn, R M; Schwartz, K; Patthy, L (1997) Convergent evolution of apolipoprotein(a) in primates and hedgehog. Proc Natl Acad Sci U S A 94:11992-7
Hughes, S D; Lou, X J; Ighani, S et al. (1997) Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus. J Clin Invest 100:1493-500
Boonmark, N W; Lou, X J; Yang, Z J et al. (1997) Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. J Clin Invest 100:558-64
Hughes, S D; Rubin, E M (1997) Vascular accumulation of Lp(a): in vivo analysis of the role of lysine-binding sites using recombinant adenovirus. Clin Genet 52:361-6